Last reviewed · How we verify

Biostate® [RP]

CSL Behring · Phase 2 active Biologic

Biostate is a recombinant human C1 esterase inhibitor used to treat hereditary angioedema.

Biostate is a recombinant human C1 esterase inhibitor used to treat hereditary angioedema. Used for Hereditary angioedema.

At a glance

Generic nameBiostate® [RP]
Also known asBiostate®, Human Coagulation Factor VIII / von Willebrand Factor
SponsorCSL Behring
Drug classC1 esterase inhibitor
TargetC1 esterase complex
ModalityBiologic
Therapeutic areaImmunology
PhasePhase 2

Mechanism of action

It works by inhibiting the C1 esterase complex, which is involved in the activation of the complement system and the release of bradykinin, a potent vasodilator. This leads to decreased levels of bradykinin and reduced inflammation in blood vessels, alleviating symptoms of hereditary angioedema.

Approved indications

Common side effects